" /> PhenX - human papillomavirus vaccine use protocol 100801:-:Pt: Patient:-:PhenX - CISMeF





Preferred Label : PhenX - human papillomavirus vaccine use protocol 100801:-:Pt: Patient:-:PhenX;

LOINC status : TRIAL;

LOINC long common name : PhenX - human papillomavirus vaccine use protocol 100801;

LOINC short name : HPV vaccine use proto;

LOINC description : The interviewer asks the female participant whether she has ever received a human papillomavirus (HPV) vaccination. If she answers yes, the interviewer asks her age and how many shots she received. If the participant answers yes to question 1, the interviewer should complete the rest of the protocol. If the participant answers no then the protocol is deemed complete. The PhenX Working Group notes that GARDASIL is also known as Silgard. European Medicines Agency. (September 25, 2009). Silgard European Public Assessment Report. Retrieved from http://www.emea.europa.eu/humandocs/Humans/EPAR/silgard/silgard.htm. Waknine, Yael. (October 2, 2006). International Approvals: Singulair and Gardasil/Silgard. Medscape Today. Retrieved from http://www.medscape.com/viewarticle/545374.;

Details


You can consult :


Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.